Citation

Gaur V, Salvi D, Gautam M, Sangwan V, Tambi T, Kalia A, Singh N. Indian J. Psychiatry 2022; 64(1): 89-92.

Copyright

(Copyright © 2022, Medknow Publications)

DOI

10.4103/indianjpsychiatry.indianjpsychiatry_312_21

PMID

unavailable

Abstract

Aims: To identify prevalence of psychiatric comorbidity in clinically stable COVID-19 patients.

MATERIALS AND METHODS: A cross-sectional single point observational study was conducted among clinically stable 72 COVID-19 infected patients. Psychiatric comorbidity was assessed with the help of DSM-5 Self-Rated Level 1 CCSM - Adult scale.

RESULTS: The prevalence of psychiatric comorbidity was 76.4% (n = 55). Depression was the most common diagnosis in 44.44% (n = 32) followed by anxiety (34.72%, n = 25), somatic symptoms (26.39%, n = 19), sleep problems (23.61%, n = 17). Around 45.83 % (n = 33) patients considered COVID-19 infection as potentially life-threatening and 23.62% (n=17) patients experienced discrimination and stigma after being diagnosed with COVID-19 infection. Using binary logistic regression, physical symptoms was identified as a risk factor for psychiatric comorbidity.

CONCLUSION: Our study provides evidence of a significant impact of COVID-19 infection on mental health in COVID-19 patients. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.

Language: en

Keywords

memory; adult; human; mental health; COVID-19; suicide; female; male; depression; prevalence; anger; anxiety; psychosis; substance use; Coronavirus; comorbidity; risk factor; fatigue; major clinical study; mental disease; questionnaire; sleep disorder; cross-sectional study; fever; mania; infection; psychiatric disorder; Article; observational study; somatoform disorder; psychological; impact; coronavirus disease 2019; DSM 5 self rated level 1